NPAR、NLR与ELR对COPD患者死亡率的预测作用:NHANES 2011-2018证据
本研究基于美国NHANES 1999-2018数据,纳入1158名40-79岁医生诊断COPD的社区成人,采用Cox回归和ROC曲线分析NPAR、NLR、ELR对全因、心血管病及慢性下呼吸道疾病死亡率的预测作用。结果显示较高NPAR与全因、CVD及CLRD死亡率增加相关,较高NLR与全因及CVD死亡率增加相关,NPAR预测5年全因死亡的AUC为0.808,优于其他血液炎症标志物。
要点
- 较高NPAR与COPD患者全因、CVD及CLRD死亡率增加独立相关。
- 较高NLR与全因及CVD死亡率增加相关,ELR与各死亡率无显著关联。
- NPAR预测5年全因死亡的AUC为0.808,优于NLR的0.799。
核心结论
- 在社区居住的美国COPD成人中,较高NPAR和NLR与死亡风险增加相关。
- NPAR在预测5年全因死亡率方面优于其他血液炎症生物标志物。
研究设计与样本
- 纵向研究,提取美国NHANES 1999-2018数据中40-79岁医生诊断COPD的成人资料。
- 共分析1158名受试者,采用Cox回归分析NPAR、NLR、ELR及其组分与全因、CVD及CLRD死亡率的关联。
- 采用ROC曲线分析评估这些生物标志物对5年全因死亡的预测性能。
主要发现
- 调整后,较高NPAR与全因死亡率(aHR=1.14)、CVD死亡率(aHR=1.15)及CLRD死亡率(aHR=1.16)增加显著相关。
- 较高NLR与全因死亡率(aHR=1.16)及CVD死亡率(aHR=1.29)增加相关。
- 较高中性粒细胞与全因死亡率(aHR=1.13)及CLRD死亡率(aHR=1.34)增加相关。
- 白蛋白与全因死亡率(aHR=0.91)及CVD死亡率(aHR=0.86)降低相关。
- ELR、嗜酸性粒细胞或淋巴细胞与任何死亡结局均无显著关联。
关键数值与推荐
- NPAR预测5年全因死亡的调整AUC为0.808(95% CI: 0.722-0.845)。
- NLR预测5年全因死亡的调整AUC为0.799(95% CI: 0.763-0.835)。
临床怎么用
- NPAR和NLR可作为社区COPD患者死亡风险分层的血液炎症标志物。
- NPAR对5年全因死亡的预测性能优于NLR、ELR及其组分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: This study evaluated the predictive roles of hematologic inflammatory biomarkers including neutrophil-percentage-to-albumin ratio (NPAR), neutrophil-to-lymphocyte ratio (NLR) and eosinophil-to-lymphocyte ratio (ELR) for mortality in community-dwelling individuals with chronic obstructive pulmonary disease (COPD). METHODS: This longitudinal study extracted data of adults 40-79 years who had physician-diagnosed COPD from the United States (US) National Health and Nutrition Examination Survey (NHANES) 1999-2018. Cox regressions determined the associations between NPAR, NLR, ELR and their components, with all-cause mortality, cardiovascular disease (CVD) mortality and mortality from chronic lower respiratory disease (CLRD). Receiver operating characteristic (ROC) curve analysis estimated the predictive performances of these biomarkers for 5-year all-cause mortality. RESULTS: Data of 1158 subjects were analysed. After adjustment, higher NPAR was significantly associated with increased all-cause and CVD mortality, and mortality from CLRD (adjusted hazard ratio [aHR] = 1.14, 1.15 and 1.16). Higher NLR was associated with an increased all-cause and CVD mortality (aHR = 1.16 and 1.29). Higher neutrophil was associated with increased all-cause mortality and mortality from CLRD (aHR = 1.13 and 1.34). Albumin was associated with decreased all-cause and CVD mortality (aHR = 0.91 and 0.86). ELR, eosinophil or lymphocyte was not significantly associated with either mortality outcomes. Adjusted AUC of NPAR and NLR in predicting 5-year all-cause mortality were 0.808 (95% CI: 0.722-0.845) and 0.799 (95% CI: 0.763-0.835), respectively. CONCLUSION: In community-dwelling US adults with COPD, increased NPAR and NLR are associated with mortality risks. NPAR outperforms the other hematologic inflammatory biomarkers in predicting 5-year all-cause mortality.
引用
- Lan CC, Su WL, Yang MC, et al. Predictive role of neutrophil-percentage-to-albumin, neutrophil-to-lymphocyte and eosinophil-to-lymphocyte ratios for mortality in patients with COPD: Evidence from NHANES 2011-2018. Respirology. 2023. PMID: 37655985. doi:10.1111/resp.14589
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。